Prothena Stock Price (NASDAQ:PRTA)

Add to My Stocks
$14.62 $0.24 (1.62%) PRTA stock closing price May 25, 2018 (Closing)
Prev Close* : $14.86
Market Cap:
$591.76M
Day Low: $14.48
52 Week Low: $10.43
Open: $14.83
Volume: -
Day High: $15.15
52 Week High: $70.00
Dividend:
0.00

Latest Stock Market News

Latest Articles

Prothena News - From Partners

PRTA Stockcharts

View PRTA PE ratio, PS ratio stocks charts and compare with peers.
PRTA Chart
Note: Compare Prothena stock price history with the index and industry peers.

Prothena Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
20.91
PB ratio (
price to book ratio
)
1.28

Prothena Returns

ROE
(return on equity)
-37%

Prothena Financial Ratios

Asset Turnover
0
Receivables Turnover
1.05
Debt to Equity
0
Dividend Yield
0%

PRTA Industry Peers

Company Price Change (%)
Novavax (NVAX)1.680.04 (2.33%)
Five Prime Therapeutics (FPRX)18.490.08 (0.43%)
Cynapsus Therapeutics (CYNA)40.480 (0%)
Intec Pharma (NTEC)4.450.13 (2.84%)
Bellus Health (BLUSF)0.450.02 (4.26%)
Alkermes (ALKS)45.770.35 (0.77%)
Forward Pharma (FWP)2.920.19 (6.11%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Mirati Therapeutics (MRTX)44.355.3 (13.57%)
Fortress Biotech (FBIO)3.450.32 (10.22%)
Cara Therapeutics (CARA)17.021.46 (9.38%)
Keryx Biopharma (KERX)5.250.25 (5%)
BioMarin Pharma (BMRN)92.494.21 (4.77%)
Ultragenyx Pharma (RARE)67.312.81 (4.36%)
Horizon Pharma (HZNP)16.170.65 (4.19%)
Top gainers from Medical-Biomed-Genetics industry
* As of May 25, 2018
CompanyPriceChange (%)
Vital Therapies (VTL)5.70.45 (7.32%)
Verastem (VSTM)5.380.35 (6.11%)
MiMedx (MDXG)8.350.52 (5.86%)
Momenta Pharma (MNTA)23.051.3 (5.34%)
Chromadex (CDXC)3.440.17 (4.71%)
SANGAMO THERAP (SGMO)15.60.7 (4.29%)
BioDelivery Sciences (BDSI)2.40.1 (4%)
Top losers from Medical-Biomed-Genetics industry
* As of May 25, 2018

Prothena Corporation PLC Stock News - Partner Headlines

Prothena Financial Statements

income statement20172016201520142013
Net Sales or Revenues27.51M1.05M1.6M50.85M-
Net Income-153.23M-160.1M-80.61M-7.15M-40.99M
Total Operating Expense182.76M160.58M81.53M57.5M41.1M
View Prothena income statement
balance sheet20172016201520142013
Total Assets496.32M459.97M385.23M304.11M182.41M
Total Liabilities89.14M94.57M24.56M14.22M9.14M
Shareholders Equity407.18M365.4M360.66M289.88M173.27M
View Prothena balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities-7.16M18.88M11.47M1.37M5.67M
Net Cash from (used by) Operating Activities-131.18M-117.26M-62.45M-0.68M-32.09M
Increase (Decrease) in Prop Plant And Equipment-3.52M-16.64M-1.38M-0.49M-0.53M
View Prothena cash flow statement

Prothena Stock Message Board

Prothena stock lost 1.62%, and the last close price as of May 25, 2018 is $14.62 for PRTA stock. Prothena market capitalization is $591.76M and it represents the total market value of PRTA stock. Prothena valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Prothena is worth a lot, it will most likely be reflected in an inflated Prothena stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Prothena stock quote data shows the number of shares traded. For Ex: 403,893 Prothena shares were traded as of last trading day, as seen from Prothena stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Prothena stock dividend was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Prothena stock price history.